Evidence map›Paper›PMID 28448550›Full record

ArticlePloS one2017

Priority target conditions for algorithms for monitoring children's growth: Interdisciplinary consensus.

Pauline Scherdel, Rachel Reynaud, Christine Pietrement, Jean-François Salaün, Marc Bellaïche, Michel Arnould, Bertrand Chevallier, Hugues Piloquet, Emmanuel Jobez, Jacques Cheymol and 4 more

Abstract readConsensus Statement
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Pauline ScherdelINSERM, UMR1153 Epidemiology and Biostatistics Sorbonne Paris Cité Center (CRESS), early ORigins of the Child's Health and Development Team (ORCHaD), Paris Descartes University, Paris, France.
Rachel ReynaudSociété Française d'Endocrinologie et Diabétologie Pédiatrique, Marseille, Centre de Recherche en Neurobiologie et Neurophysiologie de Marseille (CRN2M), Centre National de la Recherche Scientifique, UMR 7286, Aix-Marseille University, Marseille, France.
Christine PietrementSociété de Néphrologie Pédiatrique, Department of Pediatrics (Nephrology unit), University Hospital of Reims, Reims, Laboratory of Biochemistry and Molecular Biology, Faculty of Medicine, Reims, France.
Jean-François SalaünAssociation Française de Pédiatrie Ambulatoire, Commission Recherche, Gradignan, Pediatric office, St-Brieuc, France.
Marc BellaïcheGroupe Francophone d'Hépato-Gastroentérologie et Nutrition Pédiatriques and Department of Pediatric Gastroenterology and Nutrition, Robert-Debré hospital, AP-HP, Paris, France.
Michel ArnouldSociété Française de Médecine Générale, Commission Recherche, Orléans, Institut de Chimie Organique et Analytique (ICOA), Orléans University, UMR-CNRS 7311, Orléans, France.
Bertrand ChevallierGroupe de Pédiatrie Générale - Société Française de Pédiatrie, Boulogne-Billancourt, Department of Pediatrics and Pediatric Emergency, Ambroise-Paré hospital, Boulogne-Billancourt, France.
Hugues PiloquetGroupe Francophone d'Hépato-Gastroentérologie et Nutrition Pédiatriques, Nantes, Division of Pediatric Gastroenterology, hôpital Mère-Enfants, Nantes, France.
Emmanuel JobezSociété de Formation Thérapeutique du Généraliste, Commission Recherche, Paris, France.
Jacques CheymolCommission de Santé Publique et de Pédiatrie Sociale - Société Française de Pédiatrie, Clichy, France.
Emmanuelle BicharaDepartment of General Pediatrics, Necker Children's Hospital, AP-HP, Paris Descartes University, Paris, France.
EBGM III study group
Barbara HeudeINSERM, UMR1153 Epidemiology and Biostatistics Sorbonne Paris Cité Center (CRESS), early ORigins of the Child's Health and Development Team (ORCHaD), Paris Descartes University, Paris, France.
Martin ChalumeauINSERM, UMR1153 Epidemiology and Biostatistics Sorbonne Paris Cité Center (CRESS), Obstetrical, Perinatal and Pediatric Epidemiology Research Team (EPOPé), Paris Descartes University, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGrowth monitoring of apparently healthy children aims at early detection of serious conditions through the use of both clinical expertise and algorithms that define abnormal growth. Optimization of growth monitoring requires standardization of the definition of abnormal growth, and the selection of the priority target conditions is a prerequisite of such standardization.

objectiveTo obtain a consensus about the priority target conditions for algorithms monitoring children's growth.

methodsWe applied a formal consensus method with a modified version of the RAND/UCLA method, based on three phases (preparatory, literature review, and rating), with the participation of expert advisory groups from the relevant professional medical societies (ranging from primary care providers to hospital subspecialists) as well as parent associations. We asked experts in the pilot (n = 11), reading (n = 8) and rating (n = 60) groups to complete the list of diagnostic classification of the European Society for Paediatric Endocrinology and then to select the conditions meeting the four predefined criteria of an ideal type of priority target condition.

resultsStrong agreement was obtained for the 8 conditions selected by the experts among the 133 possible: celiac disease, Crohn disease, craniopharyngioma, juvenile nephronophthisis, Turner syndrome, growth hormone deficiency with pituitary stalk interruption syndrome, infantile cystinosis, and hypothalamic-optochiasmatic astrocytoma (in decreasing order of agreement).

conclusionThis national consensus can be used to evaluate the algorithms currently suggested for growth monitoring. The method used for this national consensus could be re-used to obtain an international consensus.

Indexed as

AlgorithmsGrowth and DevelopmentInterdisciplinary StudiesChildHumansPilot Projects

Identifiers

PMID28448550
PMCPMC5407643

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.